Experts Find Obesity Drug Can Reduce Body Weight by Up to 28%
Obesity is a health condition that is not only related to body weight but is also closely linked to high blood pressure and cholesterol, which can trigger serious diseases causing premature death.
Indonesia ranks fifth among Southeast Asian countries with the highest obesity rates. According to the latest data from the World Obesity Federation, the prevalence of obesity in Indonesia stands at 11.52 per cent.
New research presented at the European Congress on Obesity (ECO) 2026 shows that a high-dose obesity therapy can lead to substantial weight loss. The findings indicate that some patients using the 7.2 milligram dose of Wegovy experienced an average weight reduction of up to 27.7 per cent after 72 weeks of therapy.
However, the results come with certain limitations. The 27.7 per cent weight loss was only observed in approximately one in four patients who showed a rapid response to the therapy, meaning not all users can expect similar outcomes. Patients who were not classified as “early responders” still achieved a clinically meaningful average weight loss of 15.4 per cent.
Dr Dror Dicker, Associate Clinical Professor of Internal Medicine at Tel Aviv University, emphasised that such varying results are normal in medical practice. He noted that even the weight loss seen in the non-early responder group is substantial and clinically significant.
Source: jawawa.id (https://jawawa.id/newsitem/experts-find-obesity-drug-can-reduce-body-weight-by-up-to-28-1783939975)
Originally published by CNBC Indonesia (https://www.cnbcindonesia.com/lifestyle/20260713143648-33-750410/ahli-temukan-obat-obesitas-bisa-pangkas-berat-badan-hingga-28), translated from Indonesian